Palvella Therapeutics Inc (PVLA)
SG&A Expense Growth
61.78%
Quarterly · Period ending:
PVLA SG&A Expense Growth
Latest reported61.78%period ending
Latest reported61.78%period ending
PVLA Quarterly SG&A Growth (QoQ) (0.00% → 61.78%)
Latest values, visible window
High-resolution chart · PNG
PVLA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 61.7823% | |
| 31.9866% | |
| 14.6341% | |
| -11.6893% | |
| 8.8228% | |
| 108.283% | |
| -3.0319% | |
| 28.2401% | |
| 89.1613% | |
| -66.6953% | |
| -61.8525% | |
| 64.9986% | |
| -8.8736% | |
| 0% |